Cipta Sarana Medika Tbk. vs Pudjiadi & Sons Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Pudjiadi & Sons Tbk. trades at Rp500 (market cap 398.91B, 9.9K 24h volume). The key difference: Pudjiadi & Sons Tbk. is far larger — about 2.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 9.9K). Which is the better fit depends on your goals.
| DKHH | PNSE | |
|---|---|---|
Market Cap | 158.12B | 398.91B |
Volume | 8.21M | 9.9K |
Lot | 82.15K | 99 |
Turnover | 515.2M | 4.94M |
Average Price | 62.72 | 499.47 |
Value | 515.2M | 4.94M |
Indicative Equilibrium Price | 63 | — |
Indicative Equilibrium Volume | 1.33K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Read more on PNSE →